日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Trends and Disparities in Heat-Related Emergency Medical Services Activations

与高温相关的紧急医疗服务启动趋势和差异

Lim, Chris Chaeha; Race, Jonathan A; Kaur, Parneet; Kim, Honghyok; Wei, Ran; Li, Xiaojiang; Keith, Ladd; Gerald, Lynn B; Drummond, Brian; Tolby, Noah M; Mann, N Clay

Early Experience with Tarlatamab (T-Cell Engagers) for Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Canada: Lessons Learned and Implementation Strategies

加拿大早期应用Tarlatamab(T细胞衔接器)治疗广泛期小细胞肺癌(ES-SCLC)的经验:教训和实施策略

Cheema, Parneet K; Perdrizet, Kirstin A; Sangha, Randeep S; Breadner, Daniel; Daaboul, Nathalie; Farley, Shannon; Jao, Kevin; Liu, Geoffrey; Logan, Becky; Melosky, Barbara; Reiman, Anthony; Snow, Stephanie; Yadav, Sunil; Kassam, Shaqil

A high fermentable fiber Western diet reduces indole levels

高发酵纤维的西式饮食可降低吲哚水平

Priyadarshini, Medha; Jorgensen, Julianne; Stauffer, Sophia R Chang; Issa, Lina; Pandya, Nupur; Nnyamah, Chioma; Xu, Kai; Boyett, James E; Kular, Parneet; Mhatre, Aditi; Brahambhatt, Vishal H; Gilbert, Jack A; Khan, Md Wasim; Wicksteed, Barton; Dai, Yang; Layden, Brian T

Co-designed films to reduce care burden in India: The Moving Pictures pilot trial

共同设计影片以减轻印度的照护负担:“动态影像”试点试验

Brijnath, Bianca; Rao, Rachita; Varghese, Mathew; Antoniades, Josefine; Baruah, Upasana; Sethi, Parneet; Cooper, Claudia; Dow, Briony; Kent, Mike; Bhaskarapillai, Binukumar; Loganathan, Santosh

Interpreter Communication Quality in Cognitive Assessments for Dementia: The MINDSET Randomized Clinical Trial

认知评估中口译员沟通质量对痴呆症的影响:MINDSET随机临床试验

Brijnath, Bianca; Markusevska, Simona; Enticott, Joanne; Sethi, Parneet; Gilbert, Andrew S; Gonzalez, Erika; Hlavac, Jim; Low, Lee-Fay; LoGiudice, Dina; Woodward-Kron, Robyn; Antoniades, Josefine; Lin, Xiaoping; Hwang, Kerry; White, Jennifer; Cavuoto, Marina

Statewide Transfer Coordination and Patient Transfer Rates Among Hospitals During Occupancy Stress

全州医院间转诊协调及患者转诊率在医院入住压力下的变化

Richert, Mary E; Diao, Guoqing; Mancera, Alex; Badesch, Brittany; Neupane, Maniraj; Amirahmadi, Roxana; Sarzynski, Sadia H; Warner, Sarah; Weissman, Joel S; Goralnick, Eric; Franklin, Brian J; Swihart, Bruce J; Villarroel, Lisa; Hick, John L; Mitchell, Steven H; Kaur, Parneet; Fisher, Benjamin; Kadri, Sameer S

CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 (NRG1) Fusions

CRESTONE:一项评估HER3单克隆抗体Seribantumab治疗伴有Neuregulin-1 (NRG1)融合的实体瘤的疗效和安全性的II期研究

Patil, Tejas; Lin, Jessica J; Cheema, Parneet K; Carrizosa, Daniel R; Burkard, Mark E; Elamin, Yasir Y; Desai, Jayesh; Patel, Jyoti D; Nagasaka, Misako; Reckamp, Karen L; Waqar, Saiama N; Bauman, Jessica R; Schram, Alison M; Gadgeel, Shirish M; Ma, Patrick C; Konduri, Kartik; Nguyen, Danny; Misleh, Jamal; Bleeker, Jonathan; Weiss, Matthias; Thavaneswaran, Subotheni; Haura, Eric B; Deegan, Maegan; Kaufman, Jonathan; Srivastava, Jaya; Jansen, Valerie M; Liu, Stephen V

The continually evolving landscape of novel therapies in oncogene-driven advanced non-small-cell lung cancer

癌基因驱动的晚期非小细胞肺癌新型疗法的不断发展

Melosky, Barbara; Juergens, Rosalyn A; Banerji, Shantanu; Sacher, Adrian; Wheatley-Price, Paul; Snow, Stephanie; Tsao, Ming-Sound; Leighl, Natasha B; Martins, Ilidio; Cheema, Parneet; Liu, Geoffrey; Chu, Quincy S C

TROPION-Lung15: a randomized phase III study of osimertinib combined with datopotamab deruxtecan (Dato-DXd) or Dato-DXd alone versus platinum-doublet chemotherapy in patients with EGFR-mutated advanced non-small cell lung cancer and whose disease has progressed on prior osimertinib

TROPION-Lung15:一项随机III期研究,比较奥希替尼联合达托泊单抗德鲁西替康(Dato-DXd)或单用Dato-DXd与铂类双药化疗在EGFR突变晚期非小细胞肺癌且既往接受奥希替尼治疗后病情进展的患者中的疗效。

Tan, Daniel Shao-Weng; Nadal, Ernest; Cheema, Parneet; Wu, Yi-Long; Ahn, Myung-Ju; Tanizaki, Junko; Grainger, Ellie; Nizialek, Emily; Forcina, Alessandra; van der Gronde, Toon; Yu, Helena A

Novel Approach to Proficiency Testing Reveals Significant Variations in Biomarker Practice Leading to Critical Differences in Lung Cancer Management

一种新型能力验证方法揭示了生物标志物实践中的显著差异,这些差异导致了肺癌管理方面的关键性差异。

Bisson, Kassandra R; Beharry, Andrea; Blais, Normand; Carter, Michael D; Cheema, Parneet K; Desmeules, Patrice; Garratt, John G; Melosky, Barbara; Lo, Bryan; Snow, Stephanie; Tessier-Cloutier, Basile; Tio, Edwin; Yip, Stephen; Won, Jennifer R; Sheffield, Brandon S